57 results
8-K
EX-1.1
ITCI
Intra-Cellular Therapies Inc
18 Apr 24
Entry into a Material Definitive Agreement
5:25pm
person”), the United Nations Security Council (“UNSC”), the European Union, His Majesty’s Treasury (“HMT”) or other relevant sanctions authority
424B5
ITCI
Intra-Cellular Therapies Inc
18 Apr 24
Prospectus supplement for primary offering
5:23pm
Regulation” means Regulation (EU) 2017/1129 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018.
In addition, in the United
424B5
ITCI
Intra-Cellular Therapies Inc
16 Apr 24
Prospectus supplement for primary offering
4:37pm
of the European Union (Withdrawal) Act 2018.
In addition, in the United Kingdom, this document is being distributed only to, and is directed only
8-K
EX-10.1
ITCI
Intra-Cellular Therapies Inc
9 Aug 22
Intra-cellular Therapies Reports Second Quarter 2022 Financial Results and Provides Corporate Update
7:38am
.
1.25 “EMEA” means the European Agency for the Evaluation of Medicinal Products, or any successor agency thereto.
1.26 “EU” means the European Union
8-K
EX-1.1
g45ilrix9f brrab
5 Jan 22
Entry into a Material Definitive Agreement
5:06pm
8-K
EX-10.1
cisdl uekpr2cg4
5 Jan 22
Financial Statements and Exhibits
4:58pm
424B5
hh3yv
5 Jan 22
Prospectus supplement for primary offering
4:51pm
424B5
cpakttv ezihoejj
3 Jan 22
Prospectus supplement for primary offering
5:30pm
8-K
EX-1.1
3ecp8ny4eul 4jve7
11 Sep 20
Entry into a Material Definitive Agreement
4:47pm
424B5
z4nyh3sfsfa48
11 Sep 20
Prospectus supplement for primary offering
4:44pm
424B5
aqk9rq 6sv
9 Sep 20
Prospectus supplement for primary offering
4:40pm
8-K
EX-1.1
h3zyvkvqyll u6d
8 Jan 20
Entry into a Material Definitive Agreement
5:12pm
424B5
1o0 8xkziuwhgln7
8 Jan 20
Prospectus supplement for primary offering
5:06pm